PharmaGossipAtLast

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Tuesday, September 10, 2013

Dementia campaign could lead to over-diagnosis, say experts

Posted on 2:34 PM by Unknown


Dementia
The current prevalence of dementia is thought to be 10-30% in people over the age of 80. Photograph: John Stillwell/PA

Two-thirds of people aged 80 or over could be diagnosed with dementia in future because doctors are subjecting patients to needless investigation for and potentially damaging treatment of the disease, experts say.

The specialists in dementia, geriatric medicine and public health claim the growing trend towards older people having their risk of dementia assessed could lead to considerable over-diagnosis.

"The current prevalence of dementia is thought to be 10-30% in people over the age of 80, but the adoption of new diagnostic criteria will result in up to 65% of this age group having Alzheimer'sdisease diagnosis and up to 23% of non-demented older people being diagnosed with dementia," say the British and Australian experts, writing in the British Medical Journal.

They criticise government moves to increase the early diagnosis of dementia by identifying more people as soon as possible with mild cognitive impairment, or pre-dementia, which can be a precursor of the condition, such as through cash incentives to GP surgeries and establishing a network of memory clinics.

They claim the "political drive" in the UK and US towards early diagnosis is not backed by evidence of benefit and is part of a pointless "war against dementia" that is producing more commercial opportunities for firms that sell testing tools rather than helping patients at risk of developing the condition.

"Only 5% to 10% of people with mild cognitive impairment will progress to dementia each year, and as many as 40%-70% of people do not progress or their cognitive function may even improve," write the authors, who include Carol Brayne, professor of public health at Cambridge University.

In addition, "the neuropathology of mild cognitive impairment does not support the concept that most people with this condition are in the early stages of Alzheimer's disease," they say.

Supporters of the drive towards early diagnosis say foreknowledge that someone may develop dementia can let them draw up instructions for their future care, put their financial affairs in order and make lifestyle changes, such as eating healthily and taking more exercise, that will slow the disease's progress.

But the authors claim that an early diagnosis can lead to patients taking unproven therapies such as gingko biloba to try to delay the onset of dementia, suffering stress, distress and possible stigma, or even contemplating suicide or euthanasia.

http://www.theguardian.com/society/2013/sep/10/dementia-over-diagnosis

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted in | No comments
Newer Post Older Post Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Posts

  • Beautiful Barcelona! - Gedeon Richter ruled in breach of ABPI code
    LYNNE TAYLOR Gedeon Richter (UK) has breached the Association of the British Pharmaceutical Industry (ABPI) Code of Practice, and has brough...
  • GlaxoChinaGate contd. - Bwaaa!
    China Drug Probe 'Unfair,' Euro Group Says Thu, 09/05/2013 - 8:30am Foreign companies believe they are unfairly being singled out fo...
  • Another day, another J&J recall ... Mold found in schizophrenia drug forces Johnson & Johnson recall
    By  Bloomberg News  on September 11, 2013 at 5:25 PM, updated  September 11, 2013 at 5:27 PM Johnson & Johnson has recalled 5,000 vials ...
  • AllTrials Update
    Dear Friends Support for AllTrials around the world is growing and we need to keep it that way as we reach some crucial debates. The Europea...
  • Hurrah!
    Press Release 11 September 2013 FOR IMMEDIATE RELEASE The HRA is now implementing its plans for ensuri...
  • Advertisement
    The book addresses, in great, evidence-based detail, a general system failure caused by widespread crime, corruption, bribery and impotent d...
  • Of pigs and penicillin
    Extended Withdrawal Needed to Avoid Penicillin G Residues News US - A minimum 51-day withdrawal is necessary if penicillin G is used in pigs...
  • The Lancet has formally retracted the Jikei Heart Study paper, originally published in 2007
    . The retraction had been widely anticipated for more than a month, after a series of news reports in Japan made it clear that the long-simm...
  • Wrigley holds off on caffeinated gum as FDA reviews caffeine
    By Melissa Healy 7:54 p.m. EDT, May 9, 2013 Less than a week after the Food and Drug Administration announced that it would investigate the ...
  • Petition by Professor David Healy - please sign if you agree
    Let us see Drug Data! Drug hazards are not “trade secrets”! Drug companies maximize the sales of new drugs by hyping their benefits while do...

Categories

  • Abbott (1)
  • alltrials (1)
  • alosetron (1)
  • AstraZeneca (1)
  • Baxter (1)
  • big pharma (2)
  • bribery (7)
  • Champix (1)
  • chantix (1)
  • china (7)
  • Clinical Trails (1)
  • Clinical Trial (1)
  • corruption (5)
  • Dan Markingson (1)
  • Dan Markingson Death (1)
  • diabetes (2)
  • Diovan (1)
  • EFPIA (1)
  • glaxo (11)
  • Glaxo China bribery corruption (1)
  • gsk (7)
  • hongbao (1)
  • insurance (1)
  • Januvia (1)
  • johnson and johnson (1)
  • Lotronex (1)
  • Mefloquine (1)
  • Mental Health (1)
  • Merck (2)
  • Novartis (1)
  • pancreas (1)
  • pfizer (1)
  • pharma (1)
  • pharmaceuticals (1)
  • PhRMA (1)
  • quetiapine (1)
  • Sanofi (2)
  • scandal (1)
  • seroquel (1)
  • side effects (1)
  • suvorexant (1)
  • ucb (1)
  • Valsartan (1)
  • Zaltrap (1)

Blog Archive

  • ▼  2013 (300)
    • ▼  September (40)
      • Petition by Professor David Healy - please sign if...
      • Advertisement
      • 1boringoldman explains data transparency
      • AllTrials Update
      • Ketamine, A Darling of the Club Scene, Inspires Ne...
      • Shouldn’t Hip & Knee Replacements Come With Warran...
      • Wise words
      • GlaxoChinaGate contd. - German drug giant Bayer la...
      • Winning friends
      • Richard Smith: Is the pharmaceutical industry like...
      • Another day, another J&J recall ... Mold found in ...
      • Hurrah!
      • Pain drugs will need new warnings to alert patient...
      • Implementation of a publication strategy in the co...
      • GlaxoChinaGate contd. - GSK affirms China plans, d...
      • Dementia campaign could lead to over-diagnosis, sa...
      • Of Conflicts and Clinical Trials: Researchers Repo...
      • Slumdog Clinical Trials contd - Kenyan patients be...
      • Beautiful Barcelona! - Gedeon Richter ruled in bre...
      • Now I wonder how GSK will find the cash to pay for...
      • GlaxoChinaGate contd. - Rick Tang explains China's...
      • Deaths soar as Britain turns into nation of prescr...
      • Another J&J recall - Infant Motrin due to plastic...
      • GlaxoChinaGate contd. Now US prosecutors add China...
      • The Lancet has formally retracted the Jikei Heart ...
      • A Glut of Antidepressants
      • GlaxoChinaGate contd. - Bwaaa!
      • Takeda Put Actos Sales Ahead of Safety, Lawyer Tel...
      • It's never good when authorities talk openly of im...
      • Of pigs and penicillin
      • Riots, Rage, and Resistance: A Brief History of Ho...
      • GlaxoChinaGate contd. Reforms urged for pharma ind...
      • FDA probe Gilenya
      • GlaxoChinaGate contd.. - now HR are spotlighted. C...
      • Richard Smith, Former Editor-in-Chief, BMJ reviews...
      • Peter C Gøtzsche, Professor, Director, MD, DrMedSc...
      • Wrigley holds off on caffeinated gum as FDA review...
      • Ooh la la
      • Deadly Medicines and Organized Crime by Peter Gøtz...
      • You are welcome
    • ►  August (70)
    • ►  July (104)
    • ►  June (81)
    • ►  May (5)
Powered by Blogger.